Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Silymarin for Treatment of Acute Hepatitis In Egypt
NCT00412763Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in hepatitis comparing Silymarin with Placebo (2 arms). Primary endpoints: Symptoms and signs of acute hepatitis at week 8 and Results of liver function tests at week 8. Started Jul 2003; status: completed.
02
Drugs
silymarin
03
Conditions
hepatitis
Beyond the preview
Go deeper on NCT00412763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412763.